50 Participants Needed

Phototherapy for Shift Work Sleep Disorder

(SHIFT Trial)

PC
CF
Overseen ByCynthia Fellman-Couture, RN, BSN, PhD
No Placebo GroupAll trial participants will receive the active study treatment (no placebo)
Approved in 6 JurisdictionsThis treatment is already approved in other countries

Trial Summary

What is the purpose of this trial?

The purpose of this study is to examine the effectiveness of a personalized light exposure schedule for Shift Work Disorder (SWD) in night shift workers compared to a non-personalized light exposure schedule.

Do I need to stop taking my current medications for the trial?

The trial excludes participants using medications that impact central nervous system functioning, so you may need to stop taking such medications.

What data supports the idea that Phototherapy for Shift Work Sleep Disorder is an effective treatment?

The available research shows that phototherapy can effectively reduce sleepiness and adjust the sleep schedule for shift workers. A meta-analysis found that medium-intensity light therapy for a short time at night helps reduce sleepiness, while high-intensity light therapy helps shift the sleep schedule to better match the work hours. This suggests that phototherapy can help shift workers feel more awake and align their sleep patterns with their work schedule.12345

What safety data exists for phototherapy in treating sleep disorders?

Phototherapy, also known as light therapy, has been studied for its safety and efficacy in treating circadian rhythm sleep disorders. Safety concerns primarily involve potential ocular risks, as light can affect retinal structure and physiology. Recommendations include using lamps that avoid harmful spectral emissions, standardized therapy fixtures, and monitoring by ophthalmologists for patients with eye conditions. For those with healthy eyes, optometrist supervision is advised for extended treatments. Phototherapy should be avoided in patients with retinal disorders, and consultation with an ophthalmologist is recommended.34678

Is phototherapy a promising treatment for Shift Work Sleep Disorder?

Yes, phototherapy is a promising treatment for Shift Work Sleep Disorder. It helps reduce sleepiness and adjust the body's internal clock, making it easier for shift workers to stay alert and sleep better.345910

Eligibility Criteria

This trial is for night shift workers who've been on this schedule for at least 6 months and have Shift Work Disorder based on ICSD-3 criteria. They must work a minimum of two night shifts per week, starting between 6 PM and 2 AM, lasting from 8 to 12 hours. Pregnant individuals, those with other sleep disorders or unstable major medical conditions, heavy tobacco users, and people using certain drugs are excluded.

Inclusion Criteria

I have been diagnosed with Shift Work Disorder.
Participants must have maintained this night shift schedule for at least 6 months
Participants must have night shifts starting between 18:00 and 02:00 and lasting 8 to 12 hours
See 1 more

Exclusion Criteria

Dependence on alcohol (β‰₯ 4 beverages a day)
Heavy tobacco use (β‰₯ 10 cigarettes per day)
I have been diagnosed with a sleep disorder before.
See 6 more

Timeline

Screening

Participants are screened for eligibility to participate in the trial

2 weeks
Participants wear an Apple Watch for data collection

Pre-treatment Assessment

27-hour laboratory visit for pre-treatment assessment of DLMO with hourly saliva melatonin samples

27 hours
1 in-lab visit

Treatment

Participants follow light exposure recommendations from the SHIFT mobile application for two weeks

2 weeks

Follow-up

Participants are monitored for insomnia and daytime sleepiness post-treatment

1 week

Treatment Details

Interventions

  • Phototherapy
Trial Overview The study is testing the effectiveness of personalized light exposure schedules versus non-personalized ones in treating Shift Work Disorder among night shift workers. It aims to determine if tailoring light exposure can improve sleep quality and overall well-being.
Participant Groups
2Treatment groups
Experimental Treatment
Active Control
Group I: Personalized light conditionExperimental Treatment1 Intervention
Participants will receive light exposure recommendations from the SHIFT mobile application based on their activity levels. Participants will follow these recommendations over the course of two weeks.
Group II: Non-personalized light conditionActive Control1 Intervention
Participants will receive light exposure recommendations from the SHIFT mobile application based on their habitual sleep schedule. Participants will follow these recommendations over the course of two weeks.

Phototherapy is already approved in European Union, United States, Canada, Japan, China, Switzerland for the following indications:

πŸ‡ͺπŸ‡Ί
Approved in European Union as Phototherapy for:
  • Psoriasis
  • Eczema
  • Vitiligo
  • Neonatal Jaundice
  • Seasonal Affective Disorder
πŸ‡ΊπŸ‡Έ
Approved in United States as Phototherapy for:
  • Psoriasis
  • Eczema
  • Vitiligo
  • Neonatal Jaundice
  • Seasonal Affective Disorder
  • Shift Work Disorder
πŸ‡¨πŸ‡¦
Approved in Canada as Phototherapy for:
  • Psoriasis
  • Eczema
  • Vitiligo
  • Neonatal Jaundice
  • Seasonal Affective Disorder
πŸ‡―πŸ‡΅
Approved in Japan as Phototherapy for:
  • Psoriasis
  • Eczema
  • Vitiligo
  • Neonatal Jaundice
πŸ‡¨πŸ‡³
Approved in China as Phototherapy for:
  • Psoriasis
  • Eczema
  • Vitiligo
  • Neonatal Jaundice
πŸ‡¨πŸ‡­
Approved in Switzerland as Phototherapy for:
  • Psoriasis
  • Eczema
  • Vitiligo
  • Neonatal Jaundice
  • Seasonal Affective Disorder

Find a Clinic Near You

Who Is Running the Clinical Trial?

Henry Ford Health System

Lead Sponsor

Trials
334
Recruited
2,197,000+

American Academy of Sleep Medicine

Collaborator

Trials
29
Recruited
3,000+

Findings from Research

Phototherapy at 8,000 Lux for 1.5 hours over 5 days effectively restored sleep-wake patterns and alleviated delirium symptoms in a patient who did not respond to haloperidol, suggesting a potential alternative treatment for delirium.
The case highlights the possible link between metabolic changes due to sepsis and delirium, indicating that phototherapy may help in normalizing circadian rhythms disrupted by such conditions.
Treatment of delirium with phototherapy: a case report.Fortuyn, HD., Schoemaker, J.[2020]
A 17-year-old male with non-24 hour sleep-wake syndrome showed immediate improvement in his sleep-wake and body temperature rhythms after receiving phototherapy during hospitalization.
Polysomnography results indicated that phototherapy reduced total sleep time and stages 1 and 2 of sleep while increasing deeper sleep stages (3+4), suggesting that phototherapy can effectively normalize sleep patterns in this condition.
Case of a non-24 h sleep-wake syndrome patient improved by phototherapy.Watanabe, T., Kajimura, N., Kato, M., et al.[2004]
Phototherapy is an effective treatment for various circadian sleep-wake disorders, including advanced and delayed sleep-wake phase disorders, non-24-hour sleep-wake rhythm disorder, jet lag, and night-shift work sleep-wake disorders.
The success of phototherapy relies on specific light characteristics such as intensity, duration, timing, and wavelength, but it should be avoided in patients with retinal disorders, necessitating consultation with an ophthalmologist.
[Treating circadian sleep-wake disorders by light].Leger, D., Duforez, F., Gronfier, C.[2019]

References

Treatment of delirium with phototherapy: a case report. [2020]
Case of a non-24 h sleep-wake syndrome patient improved by phototherapy. [2004]
[Treating circadian sleep-wake disorders by light]. [2019]
CME: Light Therapy: Why, What, for Whom, How, and When (And a Postscript about Darkness). [2022]
Dose-response effects of light therapy on sleepiness and circadian phase shift in shift workers: a meta-analysis and moderator analysis. [2021]
Therapy of circadian rhythm disorders in chronic fatigue syndrome: no symptomatic improvement with melatonin or phototherapy. [2019]
Bright light therapy in focus: lamp emission spectra and ocular safety. [2007]
Treatment of circadian rhythm sleep disorders with light. [2020]
[Photoperiod phototherapy and wakefulness-sleep rhythm disorders]. [2006]
10.United Statespubmed.ncbi.nlm.nih.gov
Illuminating rationale and uses for light therapy. [2021]
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top
Terms of ServiceΒ·Privacy PolicyΒ·CookiesΒ·Security